No Data Yet
Pharmaceutical M&A deal value increased 31% year-over-year to $179.6 billion in 2025, driven by a series of mega-deals in the second half of the year as companies seek to replenish drug pipelines.
A massive 404% increase in call option volume for Taiwan Semiconductor Manufacturing (TSM) signals strong bullish sentiment, as the stock nears its 52-week high. This occurs as the broader market grows more selective on AI investments, favoring firms with proven financial strength.
Portfolio
